Conditions: Hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 894
Healthy volunteers: no

Brief summary:
The primary objective of this trial is to demonstrate that the fixed-dose combination of T80/HCTZ25 is superior as first line therapy in reducing seated trough cuff Systolic Blood Pressure(SBP) compared to the monotherapy of T80 in patients with grade 2 or grade 3 hypertension (SBP\>=160 mmHg and Diastolic Blood Pressure(DBP)\>=100 mmHg).

Detailed description:

Arms:
arm 1: Telmisartan 80 mg arm 2: Telmisartan80mg/Hydrochlorothiazide25mg

Interventions: intervention 1: Telmisartan intervention 2: Telmisartan intervention 3: Hydrochlorothiazide
Intervention descriptions: intervention 1: Telmisartan 80mg intervention 2: Telmisartan 80mg intervention 3: Hydrochlorothiazide25mg

Protocol document: